Author

P. Nilcham

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Aiba· 1 shared A. Bershadsky· 1 shared A. J. Farrugia· 1 shared C. Pang· 1 shared C. Rattanasopa· 1 shared C. Su· 1 shared D. Castano Mayan· 1 shared D. M. Cibi· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Aiba

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Semaphorin3F reduces vascular endothelial and smooth muscle cell PI3K activation and decreases neointimal plaque formation

C. Rattanasopa, D. Castano Mayan, C. Su, A. J. Farrugia, M. Corliano, P. Nilcham, C. Pang, M. Hota, S. M. Koh, W. W. Lee, D. M. Cibi, A. Aiba, M. K. Singh, S. C. Wong, O. Rotzschke, , R. R. Singaraja

This study shows that Semaphorin3F reduces PI3K activation in vascular endothelial and smooth muscle cells, leading to decreased neointimal plaque formation and increased plaque stability.

bioRxiv · Mar 22, 2022 · PreprintPhysiology